YIH
DNA icon

Y-Intercept (HK)’s Ginkgo Bioworks DNA Stock Holding History

Y-Intercept (HK)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,678
Closed -$154K – 1290
2024
Q4 		$154K Buy
+15,678
New +$134K 0.01% 1074
2024
Q3 		– Sell
-25,288
Closed -$338K – 1423
2024
Q2 		$338K Buy
25,288
+19,596
+344% +$585K 0.02% 984
2024
Q1 		$264K Buy
+5,692
New +$295K 0.02% 1015
2023
Q2 		– Sell
-939
Closed -$50K – 1363
2023
Q1 		$50K Buy
+939
New +$59.5K 0.01% 1101

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Y-Intercept (HK)'s DNA Position: Q1 2025 in Review

Y-Intercept (HK) sold out of Ginkgo Bioworks (DNA) in Q1 2025, closing a stake of 15,678 shares — an estimated $154K sold.

Y-Intercept (HK) first reported a position in DNA in Q1 2023 and held it in 4 quarters. The position peaked at $338K in Q2 2024. 167 funds tracked by Wall St. Rank hold DNA as of Q1 2025.

  • Y-Intercept (HK) reported no remaining Ginkgo Bioworks position as of Q1 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 15,678 Ginkgo Bioworks shares in Q1 2025, an estimated $154K.
  • Y-Intercept (HK) first reported a position in Ginkgo Bioworks in Q1 2023 and held it in 4 quarters.
  • Y-Intercept (HK)'s Ginkgo Bioworks position peaked at $338K in Q2 2024.
  • 167 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2025.

Based on Y-Intercept (HK)'s 13F filing for Q1 2025, filed 6 May 2025.